Swinscoe M T, Ventakasubramaniam A K, Jayne D G
Academic Surgical Unit, Level 8, Clinical Sciences Building St. James's University Hospital, Leeds LS9 7TF, United Kingdom.
Tech Coloproctol. 2005 Jul;9(2):89-94. doi: 10.1007/s10151-005-0204-7. Epub 2005 Jul 8.
Fibrin glue is increasingly used in the treatment of anal fistulae. This review aims to establish its longterm efficacy and clarify its role in this setting. A search of Medline and Pubmed databases was performed from 1966 to 2004. Data were collated regarding the type of study, fistula aetiology and complexity, technical aspects of glue application, and short- and long-term healing rates. The majority of studies comprised prospective series with fistulae of mixed aetiology. The overall healing rate was 53% with a wide variation between studies (10%-78%). The only factor that could account for this diversity was fistula complexity, with series including a high proportion of complex fistulae reporting worse outcomes. The quality of data to assess the efficacy of fibrin glue in the treatment of anal fistulae is poor and further clinical trials are needed. Fistula complexity is the main factor that adversely influences long-term healing rates.
纤维蛋白胶在肛瘘治疗中的应用日益广泛。本综述旨在确定其长期疗效,并阐明其在该领域的作用。检索了1966年至2004年的Medline和Pubmed数据库。整理了有关研究类型、瘘管病因和复杂性、胶水应用的技术方面以及短期和长期愈合率的数据。大多数研究为病因混合性瘘管的前瞻性系列研究。总体愈合率为53%,各研究之间差异很大(10%-78%)。唯一能解释这种差异的因素是瘘管复杂性,包含高比例复杂瘘管的系列研究报告的结果较差。评估纤维蛋白胶治疗肛瘘疗效的数据质量较差,需要进一步的临床试验。瘘管复杂性是对长期愈合率产生不利影响的主要因素。